Electronic Medical Record-Based Nudge to Reduce SLNB
NCT06006910 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7
Last updated 2024-02-14
Summary
The goal of this prospective, historically-controlled, quality improvement project is to determine whether and to what extent an electronic health record (EHR)-based nudge affects rates of sentinel lymph node biopsy (SLNB) in older women with ER+, early-stage, clinically node negative breast cancer.
Conditions
- Breast Cancer
- Estrogen-receptor-positive Breast Cancer
Interventions
- BEHAVIORAL
-
Column-based nudge in the EHR
The nudge is a column in EPIC that flags patients coming to the clinic as a new visit with documented ER+ breast cancer. The nudge flag can pop up when hovered over to remind surgeons of the Choosing Wisely criteria and to consider omission of SLNB.
- BEHAVIORAL
-
No column-based nudge in the EHR
No intervention control period prior to nudge deployment.
Sponsors & Collaborators
-
University of Pittsburgh Medical Center
lead OTHER
Principal Investigators
-
Priscilla F McAuliffe, MD, PhD · University of Pittsburgh Medical Center
Eligibility
- Min Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-15
- Primary Completion
- 2023-11-01
- Completion
- 2024-02-12
Countries
- United States
Study Locations
More Related Trials
-
Sentinel Lymph Node Biopsy in Patients With Breast Cancer After Neoadjuvant Therapy
NCT03556397 ·Status: COMPLETED ·Phase: NA
-
Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer
NCT04021069 ·Status: UNKNOWN
-
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Initially Node Positive Breast Cancer Patients, Could it Omit Axillary Dissection ?
NCT06130241 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Sentinel Node Biopsy and Axillary Sampling in Operable Breast Cancer
NCT00128362 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant Therapy
NCT01140776 ·Status: TERMINATED
-
Omitting Sentinel Node Procedure in Breast Cancer Patients Undergoing Breast Conserving Therapy
NCT02271828 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Impact of a Predictive Model on Sentinel Lymph Node Biopsy in Initially Lymph Node-positive, HER2-positive Breast Cancer
NCT06149377 ·Status: COMPLETED
-
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery
NCT03188393 ·Status: COMPLETED ·Phase: PHASE2
-
Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast Cancer
NCT02481128 ·Status: COMPLETED ·Phase: NA
-
Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation
NCT04854005 ·Status: ACTIVE_NOT_RECRUITING
-
Active Surveillance in Older Women With ER+ Breast Cancer
NCT07262138 ·Status: RECRUITING
-
Axillary Lymph Node Status After Completion of Preoperative Neoadjuvant Systemic Chemotherapy in Patients
NCT00507611 ·Status: COMPLETED ·Phase: NA
-
A Patient Navigation Intervention for the Improvement of Risk Management Among Women at High Risk of Breast Cancer
NCT06950008 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Near-Infrared Fluorescent Sentinel Lymph Node Mapping for Breast Cancer
NCT00721370 ·Status: COMPLETED ·Phase: PHASE1
-
Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer
NCT07217990 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Sentinel Node Biopsy Omission for Breast Cancer Patients Who Plan to Have Adjuvant Chemotherapy
NCT02610621 ·Status: WITHDRAWN ·Phase: PHASE2
-
Testing of Different Methods for Determining Whether Breast Cancer Has Spread to the Lymph Nodes
NCT00360152 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Functional Anatomical Examination of Axillary Sentinel Lymph Node Drainage in the Axillary Subregions in Early Breast Cancer
NCT01804309 ·Status: COMPLETED
-
Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy
NCT03381092 ·Status: UNKNOWN
-
Evaluation of Needle Core Biopsy of Axillary Sentinel Lymph Node in Breast Cancer
NCT02046057 ·Status: COMPLETED ·Phase: NA
-
Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients
NCT05703295 ·Status: UNKNOWN
-
Real-Time Near-infrared (NIR) Mapping of Sentinel Lymph Nodes in Breast Cancer
NCT01468649 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
What Factors Affect Breast Cancer Neoadjuvant Chemotherapy Efficacy?
NCT03501394 ·Status: UNKNOWN ·Phase: NA
-
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC
NCT07080944 ·Status: RECRUITING ·Phase: NA
-
Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer
NCT05528133 ·Status: RECRUITING ·Phase: PHASE2